Biocept, Inc. filed a voluntary petition liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware on October 13, 2023. The debtor listed its assets of $2.49 million and liabilities of $2.92 million. The debtor is represented by Matthew P. Ward of Womble Bond Dickinson (US) LLP as its legal counsel.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -99.76% |
Apr. 26 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
Apr. 02 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-99.76% | 262 | |
-4.52% | 12.35B | |
-3.76% | 8.17B | |
+6.71% | 5.77B | |
+31.48% | 5.65B | |
-10.28% | 4.1B | |
+10.72% | 2.67B | |
-61.53% | 2.57B | |
-8.27% | 2.31B | |
+16.56% | 2.02B |
- Stock Market
- Equities
- BIOCQ Stock
- News Biocept, Inc.
- Biocept, Inc. Filed for Bankruptcy